Canaccord Genuity Maintains Buy on Guardant Health, Lowers Price Target to $30
Guardant Health -2.35% Pre
Guardant Health GH | 20.35 20.35 | -2.35% 0.00% Pre |
Canaccord Genuity analyst Kyle Mikson maintains Guardant Health (NASDAQ:
GH) with a Buy and lowers the price target from $45 to $30.